ArticleCell death & disease2019

CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263.

Tianlu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.